Home
Glenmark Pharmaceuticals Limited
Press Release Apr 09 2026
Business
Apr 9 2026
4 min read

Press Release Apr 09 2026

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 09, 2026, titled "Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg".

View Attachment